Innovation Blogs

06|11|26

Beyond the Molecule: The New Reality of Oncology Commercialization 

As ASCO 2026 made clear, oncology has entered a “post-molecule” era, where clinical efficacy is no longer the primary differentiator, but a baseline expectation. In a new article for PharmaLive, Tim Lewis explores how success now depends on how well therapies integrate into an increasingly complex, overburdened care ecosystem.

12|22|25

DHC Monthly: What Pharma Marketers Should Act On for 2026 

The Digital Health Coalition’s December newsletter spotlights year‑end trends and predictions for 2026, featuring insights 18 industry leaders including Susan Perlbachs and Dan Gandor. Read the blog to learn about their key perspectives for 2026.

11|04|25

Dreamforce 2025: What Pharma Should Really Take Away

If you blinked during Dreamforce this year, you might have missed that Salesforce quietly signaled a major shift in how enterprises, including life sciences organizations, will operate in the years ahead. Let’s unpack what that transformation looks like and why it matters for pharma, especially for teams navigating compliance, content and complexity every single day.

10|23|25

Cannes Lions 2025: EVERSANA INTOUCH Celebrated in the Top 5 for Global Creativity

EVERSANA INTOUCH has been named a Top 5 Healthcare Agency in the Cannes Lions 2025 Creativity Ranking Report — a global benchmark celebrating the boldest, most brilliant work shaping culture, driving business, and redefining creativity.  

10|07|25

Looking Ahead to Dreamforce 2025

Every year, Dreamforce brings together leaders, innovators, and partners across industries to explore the future of Salesforce technology. This year feels especially pivotal for the Life Sciences sector, as new technologies and strategies are reshaping how pharma and biotech organizations work, connect, and deliver impact. Our team is proud to represent EVERSANA INTOUCH at Dreamforce […]

09|24|25

Finding the Unfindable: The Artful Ingenuity of AI-Powered Patient Finding

Millions of patients remain undiagnosed or unaware of effective treatments — delaying care and leaving brands with untapped opportunity. Traditional approaches often fall short, but AI-powered patient-finding is changing the game. Our latest POV explores how a strategic combination of diverse data, cross-disciplinary clinical expertise, and advanced AI tools — what we call Artful Ingenuity […]

09|17|25

Decoding the Future of Healthcare: What Patients Want from Their Digital Health Experience

What do patients really want from their digital health experiences? At Fierce Pharma Week 2025, industry leaders tackled this question head-on. Dan Gandor, EVP, Head of Omnichannel & Digital Transformation, delivered a compelling vision for the future, one that places patient needs and expectations at the heart of innovation.

08|26|25

EVERSANA Merges with Waltz Health to Create a New Force in Pharma Commercialization and Prescription Drug Access

EVERSANA and Waltz Health today announced a merger to form a unified healthcare platform that redefines pharmaceutical commercialization and patient access. The move integrates Waltz Health’s software-powered drug-price marketplaces and direct-to-payer model into EVERSANA’s global commercialization services, creating a next-generation approach for drug access and value in the U.S. healthcare system.

08|04|25

EVERSANA Announces Development of End-to-End AI-Powered Life Sciences Marketing Agency Built on Google Cloud Technology

CHICAGO – August 4, 2025 – EVERSANA®, a leading provider of commercialization services to the global life sciences industry, today launched a groundbreaking pharmaceutical marketing AI agency running on an end-to-end AI-powered delivery platform built on Google Cloud technology. The AI Agency, actively deployed and validated for multiple pharmaceutical brands, is 80% AI-powered and automated, reducing marketing costs and […]

06|16|25

MM+M Top 100 2025: Evolved for Where Pharma’s Going

Discover how EVERSANA INTOUCH secured a top 10 spot in the MM+M Agency 100 list and learn how we've evolved for where pharma's going with a unique approach to pharma marketing.